Exbio — Research products — Antibodies — CD and related antigens — Anti-Hu CD107b PE

Anti-Hu CD107b PE

Regulatory status

RUO

Antigen

CD107b

Clone

H4B4

Format

Reactivity

Human

Application

FC (QC tested)

Excitation laser

blue (488 nm)

Variant

100 tests

1P-672-T100

Ask for delivery term HERE

248.60 USD

25 tests

1P-672-T025

Delivery 1 week

124.30 USD

Variant

100 tests

1P-672-T100

Ask for delivery term HERE

248.60 USD

25 tests

1P-672-T025

Delivery 1 week

124.30 USD

Contact distributor

Product details

Description

Images

References

SDS download

Isotype

Mouse IgG1 kappa

Specificity

The mouse monoclonal antibody H4B4 recognizes an extracellular/luminal epitope of CD107b / LAMP-2, an extensively glycosylated 100-120 kDa widely expressed lysosome-associated protein.

Workshop

HLDA V: WS Code P007

Application

FC (QC tested)

Application details

Flow cytometry: The reagent is designed for analysis of human blood cells using 10 μl reagent / 100 μl of whole blood or 10⁶ cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests. Intracellular and extracellular staining.

Reactivity

Human

Negative species

Mouse, Rat

Immunogen

Human PBMC

Preparation

Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.

Formulation

Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

Storage and handling

Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.

Other names

LAMP-2, LAMPB

Antigen description

CD107b (lysosome-associated membrane protein-2, LAMP-2), together with CD107a / LAMP-1, is a major constituent of lysosomal membrane. The LAMP proteins are involved in lysosome biogenesis and are required for fusion of lysosomes with phagosomes, especially CD107b is important regulator in successful phagosomal maturation. CD107b deficiency causes an accumulation of autophagosomes in many tissues leading to cardiomyopathy and myopathy (Danons disease). Immature CD107b is an approximately 45 kDa protein, but after extensive glycosylation the mature glycoprotein has about 100-120 kDa.

Entrez Gene ID 3920

UniProt ID P13473

Flow cytometry surface staining pattern of anti-IgE stimulated human peripheral whole blood stained using anti-human CD107b (H4B4) PE antibody (concentration in sample 1.67 μg/ml).

Expression profiling on peripheral blood subsets using Anti-human CD107b PE antibody (clone H4B4). Adaptive panel

HCDM CDMaps standardized procedures (Kuzilkova D et al. Front Immunol. 2022;13:827898) were used for cell isolation and surface staining of blood leukocytes, with the modification of staining protocol using cytometry test tubes.
Suspension of blood leukocytes isolated from buffy coats (2 x 106 cells) was added to the mixture of anti-human CD107b PE antibody (clone H4B4, 5 µg/ml in stained blood sample) and Monocyte Blocking Buffer (#ED7747), vortexed and incubated for 20 min. Next, optimized backbone antibody panel (HLDA Adaptive) was added to test tubes, vortexed and incubated for 20 min. The residual erythrocytes were lysed with 2 ml of 10× diluted EXCELLYSE Easy solution (#ED7066) and incubated for 10 min. Finally, samples were centrifuged (670 g, 5 min.), supernatant removed and the cell pellet was resuspended in 200 µl of PBS for acquisition.

1P-672_FC_CDMaps-histogram-adaptive-intracel

Expression profiling on peripheral blood subsets using Anti-human CD107b PE antibody (clone H4B4). Intracellular staining, adaptive panel

Analysis of the antibody staining profile was performed on blood leukocytes isolated from buffy coats and permeabilized using EXCELLYSE XPerm buffer set (#ED7397).
HCDM CDMaps standardized procedures (Kuzilkova D et al. Front Immunol. 2022;13:827898) were used for leukocyte isolation.
Suspension of blood leukocytes isolated from buffy coats (2 x 10⁶ cells) was added to the mixture of optimized backbone antibody panel (HLDA Adaptive) and Monocyte Blocking Buffer (#ED7747), vortexed and incubated for 20 min.
Next, EXCELLYSE XPerm buffer set (#ED7397) was used for leukocytes permeabilization according to the instruction procedure.
Mouse monoclonal anti-human CD107b PE antibody (clone H4B4) was used in concentration 5 µg/ml in stained blood sample (2 x 10⁶ cells).

Expression profiling on peripheral blood subsets using Anti-human CD107b PE antibody (clone H4B4). Innate panel

HCDM CDMaps standardized procedures (Kuzilkova D et al. Front Immunol. 2022;13:827898) were used for cell isolation and surface staining of blood leukocytes, with the modification of staining protocol using cytometry test tubes.
Suspension of blood leukocytes isolated from buffy coats (2 x 106 cells) was added to the mixture of anti-human CD107b PE antibody (clone H4B4, 5 µg/ml in stained blood sample) and Monocyte Blocking Buffer (#ED7747), vortexed and incubated for 20 min. Next, optimized backbone antibody panel (HLDA Innate) was added to test tubes, vortexed and incubated for 20 min. The residual erythrocytes were lysed with 2 ml of 10× diluted EXCELLYSE Easy solution (#ED7066) and incubated for 10 min. Finally, samples were centrifuged (670 g, 5 min.), supernatant removed and the cell pellet was resuspended in 200 µl of PBS for acquisition.

1P-672_FC_CDMaps-histogram-innate-intracel

Expression profiling on peripheral blood subsets using Anti-human CD107b PE antibody (clone H4B4). Intracellular staining, innate panel

Analysis of the antibody staining profile was performed on blood leukocytes isolated from buffy coats and permeabilized using EXCELLYSE XPerm buffer set (#ED7397).
HCDM CDMaps standardized procedures (Kuzilkova D et al. Front Immunol. 2022;13:827898) were used for leukocyte isolation.
Suspension of blood leukocytes isolated from buffy coats (2 x 10⁶ cells) was added to the mixture of optimized backbone antibody panel (HLDA Innate) and Monocyte Blocking Buffer (#ED7747), vortexed and incubated for 20 min.
Next, EXCELLYSE XPerm buffer set (#ED7397) was used for leukocytes permeabilization according to the instruction procedure.
Mouse monoclonal anti-human CD107b PE antibody (clone H4B4) was used in concentration 5 µg/ml in stained blood sample (2 x 10⁶ cells).

Anti-human CD107b PE antibody (clone H4B4) works in flow cytometry application.

Analysis of the antibody staining profile was performed on blood leukocytes isolated from buffy coats. HCDM CDMaps standardized procedures (Kuzilkova D et al. Front Immunol. 2022;13:827898) were used for cell isolation and surface staining of blood leukocytes, with the modification of staining protocol using cytometry test tubes.
Mouse monoclonal anti-human CD107b PE antibody (clone H4B4) was used in concentration 5 µg/ml in stained blood sample (2 x 10⁶ cells).

Flow cytometry multicolor surface staining pattern of anti-IgE stimulated human peripheral blood mononuclear cells stained using anti-human CD203c (NP4D6) APC antibody (10 μl reagent / 100 μl of peripheral whole blood) and anti-human CD107b (H4B4) PE antibody (concentration in sample 1.67 μg/ml).

Separation of human CD107b positive CD203c positive basophils (red-filled) from CD107b negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of anti-IgE stimulated human peripheral whole blood stained using anti-human CD107b (H4B4) PE antibody (concentration in sample 1.67 μg/ml).

Product specific references:

Apte SH, Baz A, Groves P, Kelso A, Kienzle N: Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells. Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17475-80.
PubMed

Palmer DR, Fernandez S, Bisbing J, Peachman KK, Rao M, Barvir D, Gunther V, Burgess T, Kohno Y, Padmanabhan R, Sun W: Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells. J Gen Virol. 2007 Jan;88(Pt 1):148-56.
PubMed

Denzer K, van Eijk M, Kleijmeer MJ, Jakobson E, de Groot C, Geuze HJ: Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol. 2000 Aug 1;165(3):1259-65.
PubMed

Thedrez A, Harly C, Morice A, Salot S, Bonneville M, Scotet E: IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy. J Immunol. 2009 Mar 15;182(6):3423-31.
PubMed

Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR: Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol. 2007 Aug;81(16):8468-76.
PubMed

Guia S, Cognet C, de Beaucoudrey L, Tessmer MS, Jouanguy E, Berger C, Filipe-Santos O, Feinberg J, Camcioglu Y, Levy J, Al Jumaah S, Al-Hajjar S, Stephan JL, Fieschi C, Abel L, Brossay L, Casanova JL, Vivier E: A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. Blood. 2008 May 15;111(10):5008-16.
PubMed

Meade JL, Wilson EB, Holmes TD, de Wynter EA, Brett P, Straszynski L, Ballard PA, Trapani JA, McDermott MF, Cook GP: Proteolytic activation of the cytotoxic phenotype during human NK cell development. J Immunol. 2009 Jul 15;183(2):803-13.
PubMed

Borgne-Sanchez A, Dupont S, Langonné A, Baux L, Lecoeur H, Chauvier D, Lassalle M, Déas O, Brière JJ, Brabant M, Roux P, Péchoux C, Briand JP, Hoebeke J, Deniaud A, Brenner C, Rustin P, Edelman L, Rebouillat D, Jacotot E: Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells. Cell Death Differ. 2007 Mar;14(3):422-35.
PubMed